Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

159.02
-2.4800-1.54%
Post-market: 159.020.00000.00%19:57 EDT
Volume:1.86M
Turnover:293.89M
Market Cap:21.34B
PE:-45.39
High:162.14
Open:160.01
Low:155.63
Close:161.50
52wk High:176.58
52wk Low:53.40
Shares:134.20M
Float Shares:129.78M
Volume Ratio:1.06
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5037
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-18.07%
PB:-95.75
PE(LYR):-47.89

Loading ...

U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik

Reuters
·
Jun 02

Guardant Health assumed with an Outperform at Wolfe Research

TIPRANKS
·
Jun 02

Bitdeer Launches SEALMINER DL1 Hydro Achieving 52.5 GH/s and 149 J/GH Power Efficiency

GlobeNewswire
·
Jun 01

Why Guardant Health (GH) Is Up 9.0% After ACS Adds Shield Test to Screening Guidelines

Simply Wall St.
·
May 31

Guardant Health director Manuel Hidalgo Medina disposes of 1,000 common shares worth $130,060.10

Reuters
·
May 30

Guardant Health Chief Legal Officer John G. Saia sells USD 1.26 million in common shares

Reuters
·
May 29

Guardant Health to present 38 abstracts at ASCO 2026 meeting

TIPRANKS
·
May 28

Guardant Health (GH) Gets a Buy from Piper Sandler

TIPRANKS
·
May 28

Guardant Health set to present 38 abstracts at ASCO annual meeting

Reuters
·
May 28

Canaccord Genuity Reaffirms Their Buy Rating on Guardant Health (GH)

TIPRANKS
·
May 28

Analysts Are Bullish on Top Healthcare Stocks: Niagen Bioscience (NAGE), Guardant Health (GH)

TIPRANKS
·
May 28

Movement Alert|Guardant Health Rises 5.87% in Pre-Market Trading, Shield Blood Test Included in American Cancer Society Screening Guidelines

Market Focus
·
May 28

Guardant Health Is Maintained at Buy by BTIG

Dow Jones
·
May 28

Guardant Health price target raised to $160 from $155 at BTIG

TIPRANKS
·
May 28

Movement Alert|Guardant Health Rises 5.26% in Regular Trading, Shield Blood Test Included in American Cancer Society Screening Guidelines

Market Focus
·
May 28

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Amid S&P 500, Nasdaq Rally, Middle East Peace Optimism

MT Newswires Live
·
May 27

Sector Update: Health Care Stocks Mixed Premarket Wednesday

MT Newswires Live
·
May 27

Guardant Health Says Shield Blood Test Included in American Cancer Society Guidelines

MT Newswires Live
·
May 27

Guardant Health FDA Win Sparks Interest In Liquid Biopsy Valuation Gap

Simply Wall St.
·
May 27

Guardant Health Chief Commercial Officer Chris Freeman disposes of 24,406 common shares worth $2.9 million

Reuters
·
May 27